{"version":"1.0","type":"rich","provider_name":"Acast","provider_url":"https://acast.com","height":250,"width":700,"html":"<iframe src=\"https://embed.acast.com/$/65b82968900efd00165f19d3/68bc7fcaa4a9a4d945dac663?\" frameBorder=\"0\" width=\"700\" height=\"250\"></iframe>","title":"Unpacking the Latest Keto CTA Study & the Future of Citizen Science","thumbnail_width":200,"thumbnail_height":200,"thumbnail_url":"https://open-images.acast.com/shows/65b82968900efd00165f19d3/1757183639244-98125421-3f1a-427c-a055-6d3a0919b61a.jpeg?height=200","description":"<p>📋 In this episode of Ketobiography, host Robyn Dobbins talks with Dave Feldman, a software engineer turned metabolic health researcher, about his pioneering Keto CTA study and the journey that has reshaped how we think about cholesterol and heart health. They dive into the complexities and surprises of the study’s data, the challenges of scientific transparency, and how citizen science is empowering individuals to take control of their own health. Dave also shares updates on his podcast, The Feldman Protocol, and the upcoming Cholesterol Code documentary film. This candid conversation explores perseverance, scientific rigor, and hope for the future of metabolic research.</p><p><br></p><p>⏳ Chapters</p><p>0:00 Introduction and Host Welcome</p><p>2:00 The Spark Behind Keto CTA Study</p><p>4:00 Explanation of CT Angiography and Study Details</p><p>7:00 Baseline and Longitudinal Scan Results</p><p>8:00 Semi-Quantitative vs Quantitative Data Analysis</p><p>12:00 Data Challenges and Transparency Issues</p><p>18:00 Social Media Rollout and Public Response</p><p>25:00 Engagement with HeartFlow and Data Validation</p><p>30:00 Discussion on Plaque Regression Findings</p><p>42:00 Upcoming Five-Year Scan and Future Research Plans</p><p>47:00 Launch of The Feldman Protocol Podcast</p><p>50:00 Update on Cholesterol Code Documentary Film</p><p><br></p><p>💡 What you’ll Learn in this Episode</p><ul><li>How a personal curiosity evolved into a landmark crowdfunding research study</li><li>The methodology and importance of CT angiography in understanding heart health</li><li>Differences between semi-quantitative and AI-guided quantitative analyses in plaque measurement</li><li>Challenges faced with transparency and data accuracy in scientific research</li><li>The role of citizen science and patient advocacy in advancing metabolic health knowledge</li></ul><p><br></p><p>🔑 Key Insight</p><p>“Science isn’t about having all the answers immediately — it’s about facing tough questions and letting the truth emerge through open conversation.” — Dave Feldman</p><p><br></p><p>🌐 Connect with Dave Feldman</p><p>Website: https://www.cholesterolcode.com</p><p><a href=\"https://pod.link/1836440704\" rel=\"noopener noreferrer\" target=\"_blank\">The Feldman Protocol_ Podcast</a></p><p><a href=\"https://x.com/realDaveFeldman\" rel=\"noopener noreferrer\" target=\"_blank\">X</a></p><p><br></p><p>🔬KetoCTA:</p><p><a href=\"https://www.jacc.org/doi/10.1016/j.jacadv.2025.101686\" rel=\"noopener noreferrer\" target=\"_blank\">https://www.jacc.org/doi/10.1016/j.jacadv.2025.101686</a></p><p><a href=\"https://youtu.be/ZrH8pqTiyoc\" rel=\"noopener noreferrer\" target=\"_blank\">Preliminary QAngio Data for Keto-CTA on Rapid Progressors</a></p><p><a href=\"https://youtu.be/aJobOSRdIOM\" rel=\"noopener noreferrer\" target=\"_blank\">New KETO-CTA Data - Clarification and Update on Cleerly</a></p><p><br></p><p>📌 <a href=\"https://citizensciencefoundation.org\" rel=\"noopener noreferrer\" target=\"_blank\">Citizen Science Foundation</a> &amp; <a href=\"https://cosci.org\" rel=\"noopener noreferrer\" target=\"_blank\">Collaborative Science Conference</a></p><p><br></p><p>🎬 <a href=\"https://cholesterolcodemovie.com\" rel=\"noopener noreferrer\" target=\"_blank\">The Cholesterol Code</a></p><p><br></p><p><br></p>","author_name":"Robyn R Dobbins"}